Business Wire

GSMA: Smartphones Fueling Mobile Ecosystem Growth in Latin America

Del

Smartphones now account for six out of ten mobile connections in Latin America, helping to fuel a surge in social media usage and other mobile-based services across the region. According to new data from the GSMA’s ‘Mobile Trends Report’, published at Mobile World Congress Americas this week, there were 690 million mobile connections in Latin America in the current quarter, with smartphones accounting for 60 per cent of these connections. The new report also highlights the region’s accelerating migration to 4G, which now accounts for almost a quarter of connections.

“Smartphones accounted for fewer than one in ten connections as recently as 2012, so we have seen extremely strong growth over the last few years, which has helped migrate Latin American mobile subscribers over to faster 4G networks,” said Sebastian Cabello, Head of Latin America, GSMA. “This growth has been facilitated by a decline in smartphone prices and the increasing availability of handset subsidies and finance offerings by mobile operators. Smartphones have been instrumental in establishing Latin America as one of the world’s largest consumers of social media, with the vast majority of usage occurring over mobile networks.

“Latin America’s mobile ecosystem is also supporting a fast-growing e-commerce environment, and a vibrant tech startup ecosystem based out of major regional hubs such as Sao Paulo, Buenos Aires and Mexico City.”

Top 20 Latin America markets by connections, Q3 2017

        Mobile Connections (millions

excl. M2M)

  % smartphone connections   % 4G connections
1   Brazil   234.6   73%   35%
2   Mexico   108.6   63%   25%
3   Argentina   63.3   55%   26%
4   Colombia   53.4   49%   19%
5   Peru   38.8   35%   21%
6   Venezuela   31.9   66%   12%
7   Chile   26.6   53%   29%
8   Guatemala   18.9   59%   5%
9   Ecuador   14.9   55%   22%
10   Bolivia   10.7   33%   21%
11   El Salvador   9.6   39%   4%
12   Nicaragua   9.1   40%   4%
13   Dominican R.   8.9   62%   11%
14   Honduras   8.5   54%   4%
15   Costa Rica   8.3   51%   6%
16   Paraguay   7.8   47%   17%
17   Haiti   6.5   33%   --
18   Panama   5.8   70%   6%
19   Uruguay   5.5   35%   35%
20   Cuba   4.6   40%   --
    Latin America TOTAL   690   60%   24%

Source: GSMA Intelligence

Brazil, Mexico and Argentina Leading Regional Migration to 4G Networks

4G accounts for approximately a quarter of mobile connections in the region, almost doubling from a year earlier, due to strong 4G adoption in large markets such as Brazil, Mexico and Argentina. In Brazil, 35 per cent of connections are running on 4G networks, one of the highest 4G adoption rates in the Latin America region.

For mobile operators, the increase in 4G adoption and higher mobile data consumption are contributing to an uplift in ARPU levels following several years of decline. GSMA Intelligence calculates that mobile service revenue in Latin America will grow 4 per cent year-on-year in the current quarter.

Fuelling the Startup Ecosystem

The region’s strengthening mobile economy is also helping to fuel a vibrant startup ecosystem. Funding of startups through venture capital and private equity in Latin America has surged in recent years. According to CB Insights, total funding across all sectors reached a record $5.5 billion in the first half of 2017.

According to the latest Tecnolatinas report1, Latin America’s tech startup ecosystem is valued at $37.7 billion. It notes that there are 123 ‘Tecnolatinas’ valued at over $25 million, including nine unicorns, each valued at more than $1 billion. The majority of startups identified in the report (69 per cent) are less than 10 years old. The report also highlights seven emerging areas that provide major growth opportunities for Tecnolatinas: FinTech; agri and food tech; AI and automation; synthetic biology; renewable energies; virtual and augmented reality; and the Internet of Things.

The GSMA’s second annual ‘Global Mobile Trends’ report is available to download at https://www.gsma.com/globalmobiletrends/

-ENDS-

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

1 http://tecnolatinas.com/wp-content/uploads/2017/01/TECNOLATINAS_EN_PDF_170116.pdf

Contact information

Media Contacts:
For GSMA
Clare Fenny
cfenny@webershandwick.com
T +44 20 7067 0749
or
GSMA Press Office
pressoffice@gsma.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life19.11.2017 16:31Pressemelding

Sharjah, the third largest of the United Arab Emirate’s seven emirates, was the host for the MENA region’s first ever ‘Global Relay for Life,’ (RFL) a 24-hour walkathon that is the biggest fundraising event for cancer in the world. Conducted in conjunction with the American Cancer Society, the event was organised by Friends of Cancer Patients (FoCP), a non-profit organisation that supports cancer patients and their families. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005048/en/ During MENA's first Global Relay For Life walkathon - Source: Friends of Cancer Patients Taking place November 17-18 at the American University Sharjah, the inaugural UAE RFL saw more than 2,000 relayers participating in the overnight event, with a large number of individuals and institutions involved including 52 sch

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00Pressemelding

AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20Pressemelding

AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute

Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11Pressemelding

The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other

Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20Pressemelding

Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to

Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31Pressemelding

Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom